(Nasdaq: GILD) will present additional data from the Phase 3 ASCENT study of Trodelvy ® (sacituzumab govitecan-hziy) during the upcoming San Antonio ...
News
- Gilead's Bold Ambition of Transforming Triple-Negative Breast Cancer Treatment to Be ...
- Jack Dorsey to Step Down as CEO of Twitter: 'It's Finally Time for Me to Leave' - Editorials24.com
That Bigfoot Show covers a 2009 Bigfoot sighting in San Antonio ... A Senior writer & Editor, James is a postgraduate in biotechnology and has an ...
- Satellos Bioscience: Q3 Earnings Snapshot - San Antonio Express-News
VANCOUVER, British Columbia (AP) _ Satellos Bioscience Inc. (ICOTF) on Monday reported a...
- Satellos Bioscience: Q3 Earnings Snapshot - Big Rapids Pioneer
VANCOUVER, British Columbia (AP) _ Satellos Bioscience Inc. (ICOTF) on Monday reported a... ... Metros sending the most people to San Antonio.
- Texas Biomed setting its sights on omicron variant - KSAT 12
SAN ANTONIO – Texas Biomed, one of the world's leading independent biomedical research institutions, is already working with the World Health ...